Selective kinetic spectrophotometric method for determination of gatifloxacin based on formation of its N-vinyl chlorobenzoquinone derivative

A selective and simple kinetic spectrophotometric has been developed, for the first time, for the determination of gatifloxacin (GAT) in its dosage forms. The method was based on the formation of a colored N-vinyl chlorobenzoquinone derivative of GAT by its reaction with 2,3,5,6-tetrachloro-1,4-benzoquinone in presence of acetaldehyde. The formation of the colored product was monitored spectrophotometrically by measuring the absorbances at 655 nm. The factors affecting the reaction were studied and optimized. The stoichiometry of the reaction was determined, and the reaction pathway was postulated. Under the optimized conditions, the initial rate and fixed time (at 5 min) methods were utilized for constructing the calibration graphs. The graphs were linear in the concentration ranges of 2–100 and 10–140 μg ml^?1 with limits of detection of 0.84 and 3.5 μg ml^?1 for the initial rate and fixed time methods, respectively. The analytical performance of both methods was fully validated, and the results were satisfactory. The proposed methods were successfully applied to the determination of GAT in its commercial dosage forms. The label claim percentages were 99.7–100.5 and 98.2–99.5% for the initial rate and fixed time methods, respectively. Statistical comparison of the results with those of the reference method showed excellent agreement and proved that there was no significant difference in the accuracy and precision between the reference and the proposed methods. The proposed methods are superior to all the previously reported spectrophotometric methods in terms of the procedure simplicity and assay selectivity.     

Kinetic spectrophotometric determination of pravastatin in drug formulations via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl)

A simple and sensitive kinetic spectrophotometric method for the quantitative analysis of pravastatin sodium (PVS) in pure and pharmaceutical formulations has been described. The method is based on the formation of colored product between PVS and 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) in acetone medium at 55 ± 2 °C. The reaction is followed spectrophotometrically by measuring the increase in absorbance at 462 nm as a function of time. The initial rate and fixed time methods were adopted for constructing the calibration curves. The linearity ranges were found to be 15.0–50.0 and 10.0–70.0 μg mL^?1 for initial rate and fixed time methods, respectively. The limits of detection for initial rate and fixed time methods are 0.029 and 0.086 μg mL^?1, respectively. Both methods have been applied successfully for the estimation of PVS in commercial dosage forms with no interference from the excipients. The results are compared with the HPLC pharmacopoeial method.     

Spectrophotometric and titrimetric methods for the determination of nordiazepam in pure and pharmaceutical dosage form

A spectrophotometric method and two titrimetric methods for the determination of nordiazepam via its iodobismuthate complex are described. These methods depend on the reaction of nordiazepam with potassium bismuth iodide which give an orange precipitate. Determination of nordiazepam in the precipitated complex is done iodometrically using standard potassium iodate solution or complexometrically using standard EDTA solution and xylenol orange indicator. Alternatively, the complex is dissolved in ethanol and its absorbance is measured at 323 nm. The three methods were applied for the determination of reference samples of nordiazepam in the concentration range of 1–30 mg ml^?1 (for the iodometric method) and of 5–30 mg ml^?1(for the complexometric method) and of 0.04–3.2 mg ml^?1 (for the spectrophotometric method). The proposed methods were applied for the determination of nordiazepam in madar tablets and the validity of the proposed methods was assessed by applying the standard addition technique.     

Kinetic spectrophotometric determination of hyoscine butylbromide in pure form and in pharmaceutical formulations

A simple and sensitive kinetic method was described for the determination of hyoscine butylbromide in pharmaceutical preparations. The method is based upon a kinetic investigation of the oxidation reaction of the drug with alkaline potassium permanganate at room temperature for a fixed time of 15 min. The absorbance of the colored manganate ion was measured at 610 nm. The absorbance–concentration plot was rectilinear over the range of 1.0–10 μg mL^?1 (r = 0.9999) and detection limit of 0.092 μg mL^?1. The concentration of hyoscine butylbromide was calculated using the corresponding calibration equation for the fixed-time method. The determination of hyoscine butylbromide by the fixed-concentration and rate constant methods is also feasible with the calibration equations obtained but the fixed-time method has been found to be more applicable. The different experimental parameters affecting the development and stability of the colors were carefully studied and optimized. The proposed method was applied to the determination of hyoscine butylbromide in pharmaceutical formulations. The results obtained were in good agreement with those obtained using the official British Pharmacopeial method (2004).     

Copper(II)–neocuproine reagent for spectrophotometric determination of captopril in pure form and pharmaceutical formulations

A simple, rapid, sensitive and accurate spectrophotometric method for the determination of captopril in pure form and pharmaceutical formulations is developed. The procedure is based on the reaction of copper(II) with captopril in the presence of neocuproine (NC) (2,9-dimethyl-1,10-phenanthroline) reagent in acetate buffer at pH 5.0. Copper(II) is reduced easily by captopril to Cu(I)–neocuproine complex, which shows an absorption maximum at 448 nm. Beer’s law was obeyed in the concentration range 0.3–3.0 μg mL^?1 with a minimum detection limit (LOD) of 0.039 μg mL^?1 and a quantification limit (LOQ) of 0.129 μg mL^?1. For more accurate results, Ringbom optimum concentration ranges was 0.5–2.7 μg mL^?1. The apparent molar absorbtivity and Sandell sensitivity were calculated. The validity of the proposed method was tested by analyzing the pure and pharmaceutical formulations and compared well with those obtained by the official method and demonstrated good accuracy and precision.     

UV-absorption and fluorimetric methods for the determination of alprazolam in pharmaceutical formulation

The development of UV and fluorescence spectrophotometric methods for the quantitative determination of alprazolam in dosage forms using As(III)?SDS system. The two simple and sensitive, spectrophotometric and spectrofluorimetric methods were developed for the determination of alprazolam (ALP) in tablets. These methods are based on formation of ALP?As(III) complex in the presence of SDS. The UV-spectrum of 30% methanolic solution of ALP (5 × 10^?5 M) at pH 6.5 (Mclivaine buffer) was run between 200 and 380 nm. The absorption spectrum of ALP exhibits two peaks with a λ_max. at 255 nm and a weak band at 325 nm. When the spectra of the drug were run at varying pH in the region 200–380 nm, one isosbestic point at 290 nm was observed, which indicated the presence of two ionic conditions in solution. The complex exhibited an absorption maximum at 265 nm and emission peak at 520 nm with respect to the excitation wavelength of 325 nm. The spectrophotometric method was found to be linear in 8.0–17.0 μg ml^?1 range with detection limit of 13.520 μg ml^?1, while 0.05–9.5 μg ml^?1 range was with detection limit of 1.048 × 10^?2 μg ml^?1 by spectrofluorimetric method. The mean percentage recovery of the added quantity was found to be 99.54 (spectrophotometric method) and 100.22 (spectrofluorimetric method) and the %RSD are lower than 0.478 and 0.296 determined spectrophotomerically and spectrofluorimtrically, respectively. This indicates that the proposed method is accurate. The apparent ionization constant of ALP was found to be 9.29. The spectra, experimental conditions were set followed by determination stoichiometry, stability constant and thermodynamic parameters of the As(III), Co(II), Ni(II), and Zn(II) complexes with ALP at pH 6.5. The proposed methods have been successfully applied to the assay of ALP in tablets and the results were statistically evaluated.     

Extractive-spectrophotometric methods for determination of anti-Parkinsonian drug in pharmaceutical formulations and in biological samples using sulphonphthalein acid dyes

A simple, accurate and highly sensitive spectrophotometric methods are proposed for the rapid and accurate determination of amantadine HCl (AMD) using bromocressol green (BCG), bromophenol blue (BPB) and bromothymol blue (BTB). The developed methods involve formation of stable yellow colored chloroform extractable ion-associate complexes of the amino derivative (basic nitrogen) of the AMD with three sulphonphthalein acid dyes, namely; BCG, BPB and BTB, in acidic medium. The ion-associates exhibit absorption maxima at 415, 412 and 414 nm for BCG, BPB and BTB, respectively. AMD can be determined up to 1.5–16.5, 1.4–14.0 and 1.6–17 μg mL^?1, respectively. The effect of optimum conditions via acidity, reagent concentration, time, and solvent was studied. The stoichiometry of the reaction was found to be 1:1 in all cases. The low relative standard deviation values indicate good precision and high recovery values. These methods have been successfully applied for the assay of AMD in pharmaceutical formulations. Statistical comparison of the results with the reference method shows excellent agreement and indicates no significant difference in accuracy and precision.     

Utilization of bromination reactions for the determination of carbamazepine using bromate–bromide mixture as a green brominating agent

One titrimetric and two spectrophotometric procedures have been developed for the assay of carbamazepine (CBZ) in bulk drug, formulations and spiked human urine. The methods are based on the bromination of CBZ by the bromine generated in situ by the action of the acid on the bromate–bromide mixture. The twin advantages of avoiding liquid bromine and analysis in a cost-effective manner are realized. In titrimetry, the drug was treated with a known excess of bromate–bromide mixture in hydrochloric acid medium followed by the determination of unreacted bromine iodometrically. Spectrophotometry involves the addition of a measured excess of bromate–bromide reagent in acid medium to CBZ, and after the reaction is ensured to be complete, the residual bromine was determined by reacting with a fixed amount of either methyl orange and measuring the absorbance at 510 nm (method A) or indigo carmine and measuring the absorbance at 610 nm (method B). Titrimetric procedure is applicable over the range of 1.00–7.50 mg CBZ, and the calculations are based on a 1:1 reaction stoichiometry (CBZ:KBrO₃). In spectrophotometric methods, Beer’s law is valid within concentration ranges of 0.25–1.50 and 0.50–6.00 μg ml⁻¹ CBZ for methods A and B, respectively. The proposed methods were successfully applied to the determination of CBZ in tablets and syrup, in addition to spiked human urine by the spectrophotometric methods, with mean recoveries of 95.50–104.0% and the results were statistically compared with those of an official method by applying Student’s t-test and F-test.     

A simple and sensitive spectrophotometric method for the determination of trace amounts of nitrite in environmental and biological samples using 4-amino-5-hydroxynaphthalene-2,7-disulphonic acid monosodium salt

A very simple, sensitive, fairly selective and rapid spectrophotometric method for the determination of trace amounts of nitrite has been described. This method is based on the diazotized intramolecular coupling of electrophilic diazonium cation with the phenolic group of 4-amino-5-hydroxynaphthalene-2,7-disulphonic acid monosodium salt (AHNDMS) in a phosphate buffer solution of pH 7.5. The cyclic product has a purple color with maximum absorbance at 560 nm and is stable for 6 h. Optimum reaction conditions and other important analytical parameters for the maximum color development were established. Beer's law was found to obey for nitrite in the concentration range of 0.1–1.6 μg ml^?1 with molar absorptivity of 2.6 × 10⁴ l mol^?1 cm^?1 and Sandell's sensitivity of 0.0075 μg ml^?1. The effect of interfering ions on the determination is described. The recommended method was applied for the determination of nitrite in different water, soil and human saliva samples. The performance of the recommended method was evaluated in terms of Student's t-test and variance ratio F-test, which indicated the significance of proposed method over the reference method.     

Spectrophotometric microdetermination of anti-Parkinsonian and antiviral drug amantadine HCl in pure and in dosage forms

Two simple, rapid, sensitive, low-cost, and accurate methods (A and B) for the microdetermination of amantadine HCl (AMD) in pure form and in pharmaceutical formulations are developed. Method A is based on the formation of tris (o-phenanthroline)-iron(II) complex (ferroin) upon reaction of amantadine HCl with an iron (III)-o-phenanthroline mixture in sodium acetate-acetic acid buffer media. The ferroin complex is spectrophotometrically measured at λ_max 509 nm against reagent blank. Method B is based on the reduction of Fe (III) by the drug which forms colored complex (λ_max 521 nm) with 2,2′-bipyridyl. Optimizations of the experimental conditions are described. Beer’s law is obeyed in the concentration ranges 0.4–10 and 0.6–22 μg mL^?1 using 1,10-phenanthroline and 2,2′-bipyridyl, respectively. The developed methods have been successfully applied for the determination of AMD in bulk drugs and in pharmaceutical formulations. The common excipients and additives did not interfere in their determinations.     

Spectrophotometric determination of sildenafil citrate in pure form and in pharmaceutical formulation using some chromotropic acid azo dyes

Two simple and highly sensitive spectrophotometric methods were developed for the quantitative determination of the drug sildenafil citrate (SC), Viagra, in pure form and in pharmaceutical formulations, through ion-associate formation reactions (method A) with mono-chromotropic acid azo dyes, chromotrope 2B (I) and chromotrope 2R (II) and ion-pair reactions (method B) with bi-chromotropic acid azo dyes, 3-phenylazo-6-o-carboxyphenylazo-chromotropic acid (III), bis-3,6-(o-hydroxyphenylazo)-chromotropic acid (IV), bis-3,6-(p-N,N-dimethylphenylazo)-chromotropic acid (V) and 3-phenylazo-6-o-hydroxyphenylazo-chromotorpic acid (VI). The reaction products, extractable in methylene chloride, were quantitatively measured at 540, 520, 540, 570, 600 and 575 nm using reagents, I–VI, respectively. The reaction conditions were studied and optimized. Beer's plots were linear in the concentration ranges 3.3–87.0, 3.3–96.0, 5.0–115.0, 2.5–125.0, 8.3–166.7 and 0.8–15.0 μg mL^?1 with corresponding molar absorptivities 1.02 × 10⁴, 8.34 × 10³, 6.86 × 10³, 5.42 × 10³, 3.35 × 10³ and 2.32 × 10⁴ L mol^?1 cm^?1 using reagents I–VI, respectively. The limits of detection and Sandell's sensitivities were calculated. The methods were successfully applied to the analysis of commercial tablets (Vigoran) and the recovery study reveals that there is no interference from the common excipients that are present in tablets. Statistical comparison of the results was performed with regard to accuracy and precision using Student's t- and F-tests at 95% confidence level. There is no significant difference between the reported and proposed methods with regard to accuracy and precision.     

Utility of oxidation–reduction reaction for the spectrophotometric determination of amlodipine besylate

A simple, rapid, accurate, precise and sensitive spectrophotometric method for the determination of amlodipine besylate (ADB) in bulk sample and in dosage forms is described. The method is based on oxidation of the drug by potassium permanganate in acidic medium and determine the unreacted oxidant by measuring the decrease in absorbance for five different dyes; methylene blue (MB), acid blue 74 (AB), acid red 73 (AR), amaranth dye (AM) and acid orange 7 (AO) at a suitable λ_max 663, 609, 511, 520, and 484 nm, respectively. Regression analysis of Beer's law plots showed good correlation in the concentration ranges 1.0–24, 0.9–22, 1.2–26, 0.9–12.8 and 1.0–14 μg ml^?1, respectively. The apparent molar absorptivity, Sandell sensitivity, detection and quantitation limits were calculated. For more accurate results, Ringbom optimum concentration ranges were 1.2–22.4, 1.1–20, 1.4–24.5, 1.0–12.3 and 1.3–13.2 μg ml^?1, respectively. Statistical treatment of the results reflects that the proposed procedures are precise, accurate and easily applicable for the determination of amlodipine besylate in pure form and in pharmaceutical preparations.     

Utilization of oxidation reactions for the spectrophotometric determination of captopril using brominating agents

Three simple, accurate and sensitive methods (A–C) for the spectrophotometric assay of captopril (CPL) in bulk drug, in dosage forms and in the presence of its oxidative degradates have been described. The methods are based on the bromination of captopril with a solution of excess brominating mixture in hydrochloric acid medium. After bromination, the excess brominating mixture is followed by the estimation of surplus bromine by three different reaction schemes. In the first method (A), the determination of the residual bromine is based on its ability to bleach the indigo carmine dye and measuring the absorbance at 610 nm. Method B, involves treating the unreacted bromine with a measured excess of iron(II) and the remaining iron(II) is complexed with 1,10-phenanthroline and the increase in absorbance is measured at 510 nm. In method (C), the surplus bromine is treated with excess of iron(II) and the resulting iron(III) is complexed with thiocyanate and the absorbance is measured at 478 nm. In all the methods, the amount of bromine reacted corresponds to the drug content. The different experimental parameters affecting the development and stability of the color are carefully studied and optimized. Beer's law is valid within a concentration range of 0.4–6.0, 0.4–2.8 and 1.2–4.8 μg mL^?1 for methods A, B and C, respectively. The calculated apparent molar absorptivity was found to be 5.16 × 10⁴, 9.95 × 10⁴ and 1.74 × 10⁵ L mol^?1 cm^?1, for methods A, B and C, respectively. Sandell's sensitivity, correlation coefficients, detection and quantification limits are also reported. No interference was observed from common additives found in pharmaceutical preparations. The proposed methods are successfully applied to the determination of CPL in the tablet formulations with mean recoveries of 99.94–100.11% and the results were statistically compared with those of a reference method by applying Student's t- and F-test.     

Ion-pairing and reversed phase liquid chromatography for the determination of three different quinolones: Enrofloxacin,lomefloxacin and ofloxacin

Two simple and sensitive high performance liquid chromatographic (HPLC) methods have been developed for the simultaneous determination of three different quinolones: enrofloxacin, lomefloxacin and ofloxacin in their pure and dosage forms, one with reversed phase HPLC and the other with ion-pair HPLC. In reversed phase HPLC, method (A), the mobile phase consists of 2.18% aqueous solution of KH₂PO₄ with pH adjusted to 2.4 ± 0.2 with acetonitrile (80:20; v/v), the mobile phase pumped at flow rate of 1.2 ml min^?1. A Neucleosil C₁₈ column (10 μm, 100 Å), 250 mm length × 4.6 mm diameter was utilized as stationary phase. Detection was affected spectrophotometrically at 294 nm. While in ion-pair HPLC, method (B), the mobile phase was aqueous solution of 0.65% sodium perchlorate and 0.31% ammonium acetate adjusted to pH 2.2 ± 0.2 with orthophosphoric acid: acetonitrile (81:19; v/v), the mobile phase pumped at flow rate of 1.5 ml min^?1. A μ bondapack C₁₈ column (10 μm, 100 Å), 250 mm length × 4.6 mm diameter was utilized as stationary phase. Detection was affected spectrophotometrically at 294 nm. Linearity ranges for enrofloxacin, lomefloxacin and ofloxacin were 4.0–108, 7.0–112 and 8.0–113 μg ml^?1, respectively using method A and 8.0–112, 7.0–112 and 5.0–105 μg ml^?1, respectively applying method B. Minimum detection limits obtained were 0.013, 0.023 and 0.035 μg ml^?1 for enrofloxacin, lomefloxacin and ofloxacin, respectively using method A, and 0.028, 0.023 and 0.011 μg ml^?1 using method B. The proposed methods were further applied to the analysis of enrofloxacin in injection and tablets containing the ofloxacin and lomefloxacin drugs, and the results were satisfied.     

Spectrophotometric determination of diphenhydramine hydrochloride in pharmaceutical preparations and biological fluids via ion-pair formation

A simple, sensitive and accurate spectrophotometric method has been described for the assay of diphenhydramine hydrochloride (DPH) in raw material and in biological samples. The method is based on extraction of DPH into dichloromethane as ion-pair complexes with patent blue (PB), eriochrome black T (EBT), methyl orange (MO) and bromocresol purple (BCP) in acidic medium. The coloured species exhibited absorption maxima at 632, 514, 428 and 414 nm for PB, EBT, MO and BCP, with molar absorptivity values of 1.32 × 10⁵, 2.36 × 10⁴, 3.68 × 10⁴ and 3.07 × 10⁴ l mol^?1 cm^?1, respectively. The reaction conditions were optimized to obtain the maximum colour intensity. Beer’s law was obeyed with a good correlation coefficient (0.9982–0.9993) in the concentration ranges 0.5–3, 2.0–16, 2.0–10 and 1.0–10 μg ml^?1 for PB, EBT, MO and BCP methods, respectively. The composition ratio of the ion-association complexes was found to be 1:1 in all cases as established by Job’s method. The conditional stability constant (K_f) and the free energy changes (ΔG°) were determined for all complexes formed. The proposed method was successfully applied for the determination of DPH in tablets and human urine with good accuracy and precision. Statistical comparison of the results with those obtained by the official method showed good agreement and indicated no significant difference in accuracy and precision.     

Stability-indicating liquid chromatography for determination of clopidogrel bisulfate in tablets: Application to content uniformity testing

The present study describes a simple stability-indicating reversed-phase HPLC assay for antiplatelet drug, clopidogrel bisulfate. Separation of the drug and the degradation products, under stress conditions was successfully achieved on a C-18 column utilizing 0.01 M Na₂HPO₄ (pH 4): acetonitrile in the ratio 80:20 v/v, pumped at a flow rate of 0.5 ml min^?1 with UV detection at 235 nm. The retention time of clopidogrel was 6.84 min. The method was satisfactorily validated with respect to linearity, precision, accuracy, selectivity, sensitivity and ruggedness. The response was linear in the range of 0.2–3.5 μg ml^?1 with detection limit 0.079 μg ml^?1. The suggested method was successfully applied for the analysis of clopidogrel in bulk and in commercial tablets. The results were favorably compared to those obtained by a reference method. The proposed method was successfully applied to the content uniformity testing of tablets and for determination of clopidogrel in presence of its co-administered drug, acetyl salicylic acid.     

Hollow fiber supported liquid membrane microextraction of Cu2+ followed by flame atomic absorption spectroscopy determination

Hollow fiber supported liquid membrane microextraction, a relatively new sample preparation technique, has attracted much interest in the field of environmental analysis. In the current study, a novel method based on hollow-fiber liquid-phase microextraction and flame atomic absorption spectrometry (FAAS) for the measurement of copper ion in aqueous samples is described. Hollow-fiber liquid-phase microextraction conditions such as the type of extraction solvent, pH, the stirring rate, and the amounts of chelating agents, sample volume, and the extraction time were investigated. Under the optimized conditions, the linear range was found to be 0.01–15 μg ml^?1 for copper ion, and the limit of detection to be 0.004 μg ml^?1. Tap water and surface water samples collected from Mashhad, Iran and Dorongar river; Khorasan, Iran, respectively, were successfully analyzed using the proposed method. The recoveries from the spiked water samples were 72.4% and 105%, respectively; and the relative standard deviation (RSD) at the 2 μg ml^?1 level was 6%.     

Spectrophotometric determination of carbamazepine and mosapride citrate in pure and pharmaceutical preparations

Simple, rapid and sensitive spectrophotometric methods were developed for the determination of carbamazepine and mosapride citrate drugs in pure and pharmaceutical dosage forms. These methods are based on ion pair and charge transfer complexation reactions. The first method is based on the reaction of the carbamazepine drug with Mo(V)–thiocyanate in hydrochloric acid medium followed by an extraction of the coloured ion-pair with 1,2-dichloroethane and the absorbance of the ion pair was measured at 470 nm. The second method is based on the formation of ion-pairs between mosapride citrate and two dyestuff reagents namely bromothymol blue (BTB) and bromocresol green (BCG) in a universal buffer of pH 4 and 3, respectively. The formed ion-pairs are extracted with chloroform and methylene chloride and measured at 412 and 416 nm for BTB and BCG reagents, respectively. The third method is based on charge transfer complex formation between mosapride citrate (electron donor) and DDQ (π-acceptor reagent) and the absorbance of the CT complexes was measured at 450 nm. All the optimum conditions are established. The calibration graphs are rectilinear in the concentration ranges 10–350 for carbamazepine using Mo(V)–thiocyanate and 4–100, 4–60 and 10–150 μg mL^?1 for mosapride citrate using BTB, BCG and DDQ reagents, respectively. The Sandell sensitivity (S), molar absorptivity, correlation coefficient, regression equations and limits of detection (LOD) and quantification (LOQ) are calculated. The law values of standard deviation (0.04–0.09 for carbamazepine using Mo(V)–thiocyanate and 0.022–0.024, 0.013–0.018 and 0.013–0.020 for mosapride citrate using BTB, BCG and DDQ, respectively) and relative standard deviation (0.630–2.170 for carbamazepine using Mo(V)–thiocyanate and 0.123–1.43, 0.102–0.530 and 0.226–1.280 for mosapride citrate using BTB, BCG and DDQ, respectively) reflect the accuracy and precision of the proposed methods. The methods are applied for the assay of the two investigated drugs in pharmaceutical dosage forms. The results are in good agreement with those obtained by the official method.     

Sensitive electrochemical determination of calcium dobesilate on the carbon–iron nanoparticle modified glassy carbon electrode

A carbon–iron nanoparticle modified glassy carbon electrode (CIN-GCE) has been developed for the determination of calcium dobesilate (CD) in pharmaceutical formulations. The CINs were characterized by Transmission electron microscopy and X-ray diffraction. It was found that the CIN has strong electrocatalytic effect for CD and leads to a greatly improved anodic detection of CD including higher sensitivity and better reproducibility. A detection limit of 2.0 × 10⁻⁷ M (S/N = 3) was obtained. The proposed CIN-GCE was applied to detect CD in pharmaceutical formulations with satisfactory results. The proposed CIN electrochemical sensing platform holds great promise for simple, rapid and accurate detection of CD in pharmaceutical formulations.     

Rapid determination of total iodine in Japanese coastal seawater using SF-ICP-MS

A simple and rapid analytical method to measure total iodine in seawater using sector-filed ICP-MS is presented here. The new method avoided tedious and complicated organic iodine decomposing and redox treatment. In addition, no pre-concentration and separation operations are needed. The seawater was diluted 100-fold with 0.5% TMAH prior to SF-ICP-MS analysis. Te was added as internal standard. Due to the high sensitivity of SF-ICP-MS, excellent detection limit of 0.23 ng ml^? 1 in original seawater was obtained. By applying this newly developed method, for the first time, the total iodine concentrations in Japanese coastal seawaters in 14 estuaries were investigated. An average value of 58.26 ± 6.30 ng ml^? 1 (n = 59) for total iodine concentration was obtained for future study on the estimation of sediment–water distribution coefficients and the concentration ratios from water to organisms in Japanese coastal marine environment.